Given the importance of PGC1α as a key modulator of antioxidant responses and its levels differentially downregulated in AD individuals and preserved in NDAN individuals, we wanted to further investigate its upstream regulators in the frontal cortices of control, AD, and NDAN subjects. Here, PPARGC1A is linked to Alzheimer disease.